Market Overview

UPDATE: Jefferies Raises PT on Body Central Following Soft 1Q Numbers

Related BODY
Body Central Issues Clarification on 1-for-10 Reverse Split, Effective Sept. 9th
30 Stocks Delisted So Far In 2014

In a report published Friday, Jefferies analyst Randal J. Konik reiterated a Hold rating on Body Central Corp. (NASDAQ: BODY), and slightly raised the price target from $8.00 to $9.00.

In the report, Konik noted, “BODY reported soft 1Q numbers, as expected, but we don't think it really matters as the company has a new management team in place, lowered expectations and most importantly has a very strong balance sheet (~25% of market cap). We think it will be some time before the stock potentially moves higher but see a lot of the bad news as already baked in at current levels.”

Body Central Corp. closed on Thursday at $10.28.

Latest Ratings for BODY

DateFirmActionFromTo
Oct 2013Piper JaffrayMaintainsNeutral
Sep 2013Dougherty & CompanyDowngradesBuyNeutral
Jul 2013SunTrust Robinson HumphreyInitiates Coverage onNeutral

View More Analyst Ratings for BODY
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (BODY)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional